Extracellular matrix synthesis pathway (null)

The extracellular matrix synthesis pathway encompasses all cellular processes responsible for the generation and assembly of the ECM—a three-dimensional network of proteins (such as collagens, elastin, fibronectin, laminin) and polysaccharides (glycosaminoglycans, hyaluronic acid) that provide structural support, regulate cell behavior, and mediate tissue repair[1][2][3][4][5][8]. ECM biosynthesis starts within the endoplasmic reticulum and Golgi apparatus, where precursor macromolecules undergo various modifications before secretion and extracellular assembly[1]. Cells such as fibroblasts are primary producers of ECM components, and enzymes like matrix metalloproteinases (MMPs) and lysyl oxidases (LOXs) continuously remodel the matrix to maintain tissue homeostasis and adapt to physiological needs[1][2][7]. Aberrations in ECM synthesis or remodeling underlie many pathological processes, making individual components of ECM synthesis (e.g., MMPs, integrins) important drug targets in cancer, fibrosis, and inflammatory diseases[6][7][8]. However, "extracellular matrix synthesis pathway" itself is a biological process, not a molecular entity or receptor.

Other names

ECM synthesisextracellular matrix biosynthesis pathwaymatrix production pathway

Enzyme inhibition (blocking ECM-degrading enzymes like MMPs or LOXs); Receptor antagonism (integrin antagonists modulate cell-ECM adhesion); Enzymatic degradation (hyaluronidase promotes ECM breakdown); Modulation of ECM component synthesis (some agents regulate collagen or glycosaminoglycan production)